PMDA — authorised 23 December 2022
- Marketing authorisation holder: AbbVie GK
- Status: approved
🇯🇵 FOSLEVODOPA in Japan
PMDA authorised FOSLEVODOPA on 23 December 2022
Marketing authorisation
FOSLEVODOPA in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Japan
Frequently asked questions
Is FOSLEVODOPA approved in Japan?
Yes. PMDA authorised it on 23 December 2022.
Who is the marketing authorisation holder for FOSLEVODOPA in Japan?
AbbVie GK holds the Japanese marketing authorisation.